CA2004387A1 - Proteine de liaison de la cyclosporine et utilisation dans le dosage de la cyclosporine biologiquement active - Google Patents

Proteine de liaison de la cyclosporine et utilisation dans le dosage de la cyclosporine biologiquement active

Info

Publication number
CA2004387A1
CA2004387A1 CA2004387A CA2004387A CA2004387A1 CA 2004387 A1 CA2004387 A1 CA 2004387A1 CA 2004387 A CA2004387 A CA 2004387A CA 2004387 A CA2004387 A CA 2004387A CA 2004387 A1 CA2004387 A1 CA 2004387A1
Authority
CA
Canada
Prior art keywords
cyclosporine
biologically
assay
active
binding protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2004387A
Other languages
English (en)
Other versions
CA2004387C (fr
Inventor
Steven J. Soldin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Research Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2004387A1 publication Critical patent/CA2004387A1/fr
Application granted granted Critical
Publication of CA2004387C publication Critical patent/CA2004387C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9493Immunosupressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
CA002004387A 1988-12-02 1989-12-01 Proteine de liaison de la cyclosporine et utilisation dans le dosage de la cyclosporine biologiquement active Expired - Fee Related CA2004387C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27917688A 1988-12-02 1988-12-02
US279,176 1988-12-02

Publications (2)

Publication Number Publication Date
CA2004387A1 true CA2004387A1 (fr) 1990-06-02
CA2004387C CA2004387C (fr) 2000-05-09

Family

ID=23067955

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002004387A Expired - Fee Related CA2004387C (fr) 1988-12-02 1989-12-01 Proteine de liaison de la cyclosporine et utilisation dans le dosage de la cyclosporine biologiquement active

Country Status (5)

Country Link
EP (1) EP0372862A3 (fr)
JP (1) JPH02209897A (fr)
KR (1) KR900009069A (fr)
AU (1) AU630901B2 (fr)
CA (1) CA2004387C (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2048302A1 (fr) * 1990-08-15 1992-02-16 Victoria P. Meucci Reactif de solubilisation des echantillons dans des epreuves biologiques
US5763590A (en) * 1991-10-11 1998-06-09 Vertex Pharmaceuticals, Inc. Isolation of an Mr 52,000 FK506 binding protein and molecular cloning of a corresponding human cDNA
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
MXPA04003625A (es) 2001-10-19 2004-12-02 Sotechnika Inc Sintesis de analogos de ciclosporina.
US7642059B2 (en) * 2005-09-07 2010-01-05 Roche Diagnostics Operations, Inc. Single receptor assays for immunosuppressive drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389947B (de) * 1987-04-03 1990-02-26 Woloszczuk Wolfgang Dr Verfahren zur bestimmung des aktuellen pegels von cyclosporin-a bzw. des diesem verwandter immunsuppressiva sowie jenes deren biologisch aktiver metaboliten im blut

Also Published As

Publication number Publication date
JPH02209897A (ja) 1990-08-21
KR900009069A (ko) 1990-07-02
AU630901B2 (en) 1992-11-12
EP0372862A2 (fr) 1990-06-13
CA2004387C (fr) 2000-05-09
AU4560789A (en) 1990-06-07
EP0372862A3 (fr) 1990-12-27

Similar Documents

Publication Publication Date Title
NO890921D0 (no) Fremgangsmaate for fremstilling av aminosyrederivater.
NO180362C (no) Fremgangsmåte for fremstilling av cyklosporinholdige preparater
FI896157A0 (fi) Mikrobinen menetelmä syklosporiinien valmistamiseksi
AU6785987A (en) Selecting and testing antibodies for cancer therapy
AU1756588A (en) Hybrid protein c and method for its preparation
AU3937289A (en) Hybrid protein c constructs and methods for their preparation
NO885013D0 (no) FremgangsmŸte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppnŸdd ved fremgangsmŸten.
IE882485L (en) Assay for 1,25-dihydroxy viatamin d
AU613583B2 (en) Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
CA2004387A1 (fr) Proteine de liaison de la cyclosporine et utilisation dans le dosage de la cyclosporine biologiquement active
AU649961B2 (en) Method for protein binding enzyme complementation assays
NO893794L (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
AU3890689A (en) Human protein c mutants and method for preparing the same
EP0472593A4 (en) Method for protein binding enzyme complementation assays
AU3100789A (en) New indicator compounds, method of their preparation and use of those compounds in an iron assay system
AU7160887A (en) Antiparatypical antibodies, their use for detecting and treating auto-immune diseases
EP0271964A3 (en) Method for preparing protein hydrolysates soluble in an acid environment, and the hydrolysates obtained
DK693287D0 (da) Fremgangsmaade til fremstilling af lipophile aminosyrederivater, samt herved opnaaede aminosyrederivater og anvendelsen heraf
AU5853590A (en) Assay for human ventricular myosin lc1 and monoclonal antibody thereto
AU4410689A (en) Method for sequencing peptides or proteins
AU2846689A (en) Methods for preparing proteins of altered structure
AU4329489A (en) Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer
IL82339A0 (en) Method and kit for rapid assay involving solid phase receptors
NO893796L (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
EP0260707A3 (en) Method for assaying plasma protein and measuring kit for the same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed